Safety and tolerability of once-daily versus twice-daily memantine: a randomised, double-blind study in moderate to severe Alzheimer's disease. [electronic resource]
Producer: 20080110Description: 258-62 p. digitalISSN:- 0885-6230
- Aged
- Aged, 80 and over
- Alzheimer Disease -- drug therapy
- Anxiety -- chemically induced
- Dopamine Agents -- administration & dosage
- Double-Blind Method
- Drug Administration Schedule
- Female
- Humans
- Least-Squares Analysis
- Male
- Memantine -- administration & dosage
- Mental Disorders -- chemically induced
- Neuropsychological Tests
- Patient Selection
- Safety
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.